Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (4): 448-453.doi: 10.3736/jcim20120414

Previous Articles     Next Articles

Effects of Chinese herbal medicine Feiyanning decoction on expressions of nucleosome conformation-regulating factors H3-K56, Rtt109, Asf1 and E2F1 in Lewis-bearing mice

Zhan Zheng(), Ju-yong Wang, Qing Wang, Ling Xu, Zhen-ye Xu#br#   

  1. Institute of Traditional Chinese Medicine Oncology, Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2011-11-03 Accepted:2011-12-05 Online:2012-04-20 Published:2018-04-15

Objective: Malignant tumor cells were found with an abnormal cell cycle. Previous in vivo experiment had confirmed the Feiyanning’s intervention effect on checkpoint signaling of G1/S in the cell cycle. This study was to further observe the expressions of nucleosome conformation-regulating factors intervened by Feiyanning decoction in S phase.
Methods: Lewis lung carcinoma models of C57BL/6 mice were established. Sixty mice were randomly divided into four groups: normal control group, model control group, Feiyanning group, and cisplatin group. There were 15 mice in each group. Tumor weight and tumor inhibition rate were observed. In addition, the cell cycle distribution was detected by flow cytometry and the proliferation index was calculated. Furthermore, mRNA and protein expressions of H3-K56, regulator of Ty1 transposition 109 (Rtt109), antisilencing function 1 (Asf1) and E2F1 were analyzed by real-time polymerase chain reaction and Western blot methods, respectively.
Results: The tumor weights of mice in the Feiyanning group and the cisplatin group were lower than those in the model group (P<0.01), with tumor inhibition rates of 27.92% and 42.50%, respectively. Cancer cell proliferation index and proportion of cancer cell population in S phase in the Feiyanning group were significantly lower than those in the cisplatin group (P<0.01). The mRNA and protein levels of H3-K56, Rtt109, Asf1, E2F1 in the Feiyanning group were lower than those in the model group (P<0.05).
Conclusion: Feiyanning plays a role in intervening in the abnormal cell cycle by nucleosome conformation-regulating factors and thus inhibits the lung cancer cell proliferation.

Key words: carcinoma, Lewis lung, nucleosomes, cell cycle, drugs, Chinese herbal, mice

Table 1

Primer sequences of different genes"

Gene Primer sequence Product length (bp)

Table 2

Tumor weight and tumor inhibition rate in different groups"

Group n Tumor weight (x±s, g) Tumor inhibition rate (%)
Model 15 2.83±0.16
DDP 15 1.64±0.12** 42.50
Feiyanning 15 2.04±0.14** 27.92

Table 3

S phase proportion and cancer cell proliferation index in different groups(x±s, %)"

Group n S phase proportion Proliferation index
Model 6 47.43±8.51 85.47±10.24
DDP 6 42.15±6.13 76.30±5.68
Feiyanning 6 31.35±6.11**△ 60.47±10.20**△△

Table 4

Expressions of E2F1, Rtt109, Asf1 and H3-K56 mRNAs in different groups(x±s)"

Group n E2F1 Rtt109 Asf1 H3-K56
Model 6 6.48±1.00 5.58±0.11 6.88±1.23 8.26±1.00
DDP 6 6.35±0.74 4.88±0.35* 6.12±1.11 7.57±1.12
Feiyanning 6 5.29±0.62*△ 4.52±0.71** 5.48±0.54* 4.79±0.49**△△

Table 5

Expressions of E2F1, Rtt109, Asf1 and H3-K56 proteins in different groups"

Group n E2F1 Rtt109 Asf1 H3-K56
Model 6 0.96±0.14 0.80±0.07 0.93±0.12 0.63±0.02
DDP 6 0.92±0.11 0.61±0.05* 0.89±0.11 0.53±0.05
Feiyanning 6 0.72±0.09*△ 0.48±0.05**△ 0.58±0.08**△△ 0.43±0.06**△

Figure 1

Expressions of E2F1, Rtt109, Asf1 and H3-K56 proteins in different groups DDP: cisplatin; Rtt109: regulator of Ty1 transposition 109; Asf1: antisilencing function 1."

[1] Hung RJ, Baragatti M, Thomas D, McKay J, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Chabrier A, Moullan N, Canzian F, Hall J, Boffetta P, Brennan P . Inherited predisposition of lung cancer : a hierarchical modeling approach to DNA repair and cell cycle control pathways. Cancer Epidemiol Biomarkers Prev. 2007; 16(12):2736-2744.
doi: 10.1158/1055-9965.EPI-07-0494
[2] Xu ZY, Jin CJ, Zhou CC, Wang ZQ, Zhou WD, Deng HB, Zhang M, Su W, Cai XY . Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy.J Cancer Res Clin Oncol. 2011; 137(7):1117-1122.
doi: 10.1007/s00432-011-0975-3
[3] Wang JY, Zheng Z, Xu ZY, Guo J, Su W . Effects of Feiyanning Decoction on proliferation of lung adenocarcinoma cell line and their production of interleukin-6 and interleukin-8 induced by tumor necrosis factor-a. J Chin Integr Med. 2009; 7(8): 741-745. English with abstrat in Chinese.
王菊勇, 郑展, 徐振晔, 郭净, 苏婉 . 肺岩宁方对人肺癌细胞系增殖及肿瘤坏死因子a诱导的白细胞介素6 和白细胞介素8产物的影响.中西医结合学报. 2009; 7(8) : 741-745.
[4] Zhang M, Xu ZY, Bai B, Dong Y . Feiyanning Decoction down-regulates the expressions of phosphorylated Akt and hypoxia inducible factor-la proteins in transplanted lung adenocarcinoma in nude mice. J Chin Integr Med. 2008 ; 6(6) : 616-620. Chinese with abstract in English.
张铭, 徐振晔, 白冰, 董昀 . 肺岩宁方下调裸鼠人肺腺癌细胞移植瘤中磷酸化Akt和缺氧诱导因子la蛋白表达.中西医结合学报. 2008; 6(6):616-620.
[5] Zheng Z, Wang JY Xu ZY. Effect of Feiyanning granule in antagonizing Lewis lung cancer cell proliferation through cell cycle Gi /S checkpoint dominating signaling intervention. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009; 29(11): 1018-1022. Chinese with abstract in English.
郑展, 王菊勇, 徐振晔 . 肺岩宁颗粒干预细胞周期G/ S检测点调控信号抗Lewis肺癌细胞增殖研究.中国中西医结合杂志. 2009; 29(11):1018-1022.
[6] Zhang DF. Experiments of pharmacology and traditional Chinese medicine pharmacology. Shanghai : Shanghai Scientific and Technical Publishers. 2002: 8-10. Chinese.
张大方 . 药理与中药药理实验.上海:上海科学技术出版社. 2002: 8-10.
[7] Han J, Zhou H, Horazdovsky B, Zhang KL, Xu RM, Zhang ZG . Rttl09 acetylates histone H3 lysine 56 and functions in DNA replication. Science. 2007 ; 315(5812):653-655.
doi: 10.1126/science.1133234
[8] Williams SK, Truong D, Tyler JK . Acetylation in the globular core of histone H3 on lysine-56 promotes chromatin disassembly during transcriptional activation. Proc Natl Acad Sci USA. 2008; 105(26) : 9000-9005.
doi: 10.1073/pnas.0800057105
[9] Miller A, Yang B, Foster T, Kirchmaier AL . Proliferating cell nuclear antigen and ASF1 modulate silent chromatin in Saccharomyces cerevisiae via lysine 56 on histone H3. Genetics. 2008; 179(2):793-809.
doi: 10.1534/genetics.107.084525
[10] English CM, Adkins MW, Carson JJ, Churchill ME, Tyler JK . Structural basis for the histone chaperone activity of Asfl. Cell. 2006; 127(3):458-460.
doi: 10.1016/j.cell.2006.10.021
[11] Natsume R, Eitoku M, Akai Y, Sano N, Horikoshi M, Senda T . Structure and function of the histone chaperone CIA/ ASF1 complexed with histones H3 and H4. Nature. 2007; 446(7133):338-341.
doi: 10.1038/nature05613
[12] Groth A, Corpet A, Cook AJ, Roche D, Bartek J, Lukas J, Almouzni G . Regulation of replication fork progression through histone supply and demand. Science. 2007; 318(5858) : 1928-1931.
doi: 10.1126/science.1148992
[13] Hayashi R, Goto Y, Tanaka R, Oonogi K, Hisasue M, Yoshida K . Transcriptional regulation of human chromatin assembly factor ASF1. DNA Cell Biol. 2007; 26(2):91-99.
doi: 10.1089/dna.2006.0515
[14] Hallstrom TC, Mori S, Nevins JR . An E2FI-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell. 2008; 13(1):11-12.
doi: 10.1016/j.ccr.2007.11.031
[1] Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477.
[2] Hao Gou, Ruo-chen Huang, Yong-hua Su, Wei Li. Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer. Journal of Integrative Medicine, 2021, 19(5): 408-417.
[3] Tong Zhao, Bing-jie Guo, Chu-lan Xiao, Jiao-jiao Chen, Can Lü, Fan-fu Fang, Bai Li. Aerobic exercise suppresses hepatocellular carcinoma by downregulating dynamin-related protein 1 through PI3K/AKT pathway. Journal of Integrative Medicine, 2021, 19(5): 418-427.
[4] Victor Abou Nehmi Filho, Gilson Masahiro Murata, Ruan Carlos Macêdo de Moraes, Gabriely Cristina Alves Lima, Danielle Araujo de Miranda, Katrin Radloff, Raquel Galvão Figuerêdo Costa, Joyce de Cassia Rosa de Jesus, Jéssica Alves De Freitas, Nayara Izabel Viana, Ruan Pimenta, Katia Ramos Moreira Leite, José Pinhata Otoch, Ana Flávia Marçal Pessoa. A novel supplement with yeast β-glucan, prebiotic, minerals and Silybum marianum synergistically modulates metabolic and inflammatory pathways and improves steatosis in obese mice. Journal of Integrative Medicine, 2021, 19(5): 439-450.
[5] Porwornwisit Tritripmongkol, Tullayakorn Plengsuriyakarn, Mayuri Tarasuk, Kesara Na-Bangchang. In vitro cytotoxic and toxicological activities of ethanolic extract of Kaempferia galanga Linn. and its active component, ethyl-p-methoxycinnamate, against cholangiocarcinoma. Journal of Integrative Medicine, 2020, 18(4): 326-333.
[6] He-tong Zhao, Yong-bin Meng, Xiao-feng Zhai, Bin-bin Cheng, Sha-sha Yu, Man Yao, Hui-xia Yin, Xu-ying Wan, Yun-ke Yang, Hui Liu, Feng Shen, Chang-quan Ling. Comparable effects of Jiedu granules and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study. Journal of Integrative Medicine, 2020, 18(4): 319-325.
[7] Kai-yue Tang, Shi-lin Du, Qian-lei Wang, Yi-fan Zhang, Hai-yan Song. Traditional chinese medicine targeting cancer stem cells as an alternative treatment for hepatocellular carcinoma. Journal of Integrative Medicine, 2020, 18(3): 196-202.
[8] Yi Ran Hu, San Li Xing, Chuan Chen, Ding Zhu Shen, Jiu Lin Chen. Tiaoxin Recipe, a Chinese herbal formula, inhibits microRNA-34a expression in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. Journal of Integrative Medicine, 2019, 17(6): 404-409.
[9] Jeremiah Olorunjuwon Olugbami, Robert Damoiseaux, Bryan France, Michael A. Gbadegesin, Adam Z. Stieg, Shivani Sharma, Oyeronke A. Odunola, James K. Gimzewski. Atomic force microscopy correlates antimetastatic potentials of HepG2 cell line with its redox/energy status: Effects of curcumin and Khaya senegalensis. Journal of Integrative Medicine, 2017, 15(3): 214-230.
[10] Bhesh Raj Sharma, Dong Wook Kim, Dong Young Rhyu. Korean Chungtaejeon tea extract attenuates weight gain in C57BL/6J-Lep ob/ob mice and regulates adipogenesis and lipolysis in 3T3-L1 adipocytes. Journal of Integrative Medicine, 2017, 15(1): 56-63.
[11] Shi-li Jiang, Xu-dong Hu, Ping Liu. Immunomodulation and liver protection of Yinchenhao decoction against concanavalin A-induced chronic liver injury in mice. Journal of Integrative Medicine, 2015, 13(4): 262-268.
[12] Xuanbin Wang, Ning Wang, Fan Cheung, Lixing Lao, Charlie Li, Yibin Feng. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: Current progress on pharmacological actions and mechanisms. Journal of Integrative Medicine, 2015, 13(3): 142-164.
[13] Elizabeth Abidemi Balogun, Sylvia Orume Malomo, Joseph Oluwatope Adebayo, Ahmed Adebayo Ishola, Ayodele Olufemi Soladoye, Lawrence Aderemi Olatunji, Olatunji Matthew Kolawole, Stephen Olubunmi Oguntoye, Abiola Samuel Babatunde, Oluwole Busayo Akinola . In vivo antimalarial activity and toxicological effects of methanolic extract of Cocos nucifera (Dwarf red variety) husk fibre. Journal of Integrative Medicine, 2014, 12(6): 504-511.
[14] Zhi-yi Zhou, Ling Xu, He-gen Li, Jian-hui Tian, Li-jing Jiao, Sheng-fu You, Zhi-fen Han, Yi Jiang, Hui-ru Guo​, Hui Liu​. Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: Protocol for a randomized double-blind controlled trial. Journal of Integrative Medicine, 2014, 12(3): 175-181.
[15] Md. Asadujjaman, Ahmed Ullah Mishuk, Md. Aslam Hossain, Utpal Kumar Karmakar. Medicinal potential of Passiflora foetida L. plant extracts: Biological and pharmacological activities. Journal of Integrative Medicine, 2014, 12(2): 121-126.
Full text



[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239